EMERGENT BIOSOLUTIONS INC. Effective Income Tax Rate Reconciliation Gilti Amount
EMERGENT BIOSOLUTIONS INC. (EBS) reported Effective Income Tax Rate Reconciliation Gilti Amount of $15.80 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationGiltiAmount · last filed 2026-02-27
- EMERGENT BIOSOLUTIONS INC. effective income tax rate reconciliation gilti amount for fiscal 2024 was $15.80M, a 11.24% decline from fiscal 2023.
- EMERGENT BIOSOLUTIONS INC. effective income tax rate reconciliation gilti amount for fiscal 2023 was $17.80M, a 14.01% decline from fiscal 2022.
- EMERGENT BIOSOLUTIONS INC. effective income tax rate reconciliation gilti amount for fiscal 2022 was $20.70M, a 59.23% increase from fiscal 2021.
- EMERGENT BIOSOLUTIONS INC. effective income tax rate reconciliation gilti amount for fiscal 2021 was $13.00M, a 140.74% increase from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation Gilti Amount 12 month | Effective Income Tax Rate Reconciliation Gilti Amount 12 month as first filed |
|---|---|---|
| 2024-12-31 | $15.80M 10-K · filed 2026-02-27 | |
| 2023-12-31 | $17.80M 10-K · filed 2026-02-27 | |
| 2022-12-31 | $20.70M 10-K · filed 2025-03-04 | |
| 2021-12-31 | $13.00M 10-K · filed 2024-03-08 | $11.40M 10-K · filed 2023-03-01 |
| 2020-12-31 | $5.40M 10-K/A · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |